Rheon Medical acquires the CE Marking
Share this article
Rheon Medical to launch its eyeWatch product on the Swiss and EU markets
The Vaud-based startup, Rheon Medical, specialised in non-invasive surgical treatments for glaucoma, has acquired the CE Marking for its eyeWatchTM product. This ocular implant enables an efficient control of intraocular pressure thanks to its unique technology and external control device.
Rheon Medical’s achievement is a strong synergy example between western Switzerland actors. eyeWatch is the result of an effective partnership between the Vaud-based startup and Neuchâtel-based Coat-X, which specialises in multilayer precision coating. Coat-X’ technology is used to protect eyeWatch’s magnets, which is key to the devices’ robustness.